Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
13.3%
% of MEDX's 30 holdings also in GDOC
10.8%
% of GDOC's 39 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.3% | 9.7% | 9.7% |
|
ABBVIE INC | 9.5% | 6.4% | 6.4% |
|
MERCK & CO. INC. | 3.5% | 4.0% | 3.5% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to GDOC
|
ELI LILLY & CO | 7.6% |
 |
NOVARTIS AG-ADR | 6.9% |
|
AMGEN INC | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.7% |
|
BRISTOL-MYERS SQUIBB CO | 5.6% |
|
JOHNSON & JOHNSON | 5.0% |
 |
ALKERMES PLC | 4.6% |
|
PFIZER INC | 3.9% |
|
ABBVIE INC | 3.2% |
|
ALNYLAM PHARMACEUTICALS INC | 3.0% |
MEDX Underweight Relative to GDOC
|
BOSTON SCIENTIFIC CORP | -8.3% |
|
INTUITIVE SURGICAL INC | -5.8% |
|
ABBOTT LABORATORIES | -5.2% |
|
UNITEDHEALTH GROUP INC | -5.2% |
|
INSULET CORP | -4.4% |
|
ASTRAZENECA PLC | -4.2% |
 |
NOVO NORDISK A/S-B | -3.8% |
|
COOPER COS INC/THE | -3.8% |
|
BIOMARIN PHARMACEUTICAL INC | -3.3% |
 |
CSL LIMITED | -3.1% |